Last reviewed · How we verify
Varenicline Tartrate Nasal Spray
Varenicline Tartrate Nasal Spray is a Small molecule drug developed by Corxel Pharmaceuticals. It is currently FDA-approved. Also known as: OC-01 (varenicline solution) Nasal Spray.
At a glance
| Generic name | Varenicline Tartrate Nasal Spray |
|---|---|
| Also known as | OC-01 (varenicline solution) Nasal Spray |
| Sponsor | Corxel Pharmaceuticals |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV (PHASE4)
- Effectiveness of an Enhanced Tobacco Intervention Protocol Compared to Standard Treatment in Helping Head and Neck and Lung Cancer Patients Starting Treatment to Reduce Cigarette Use (NA)
- Effectiveness of a Smoking Cessation Algorithm Integrated Into HIV Primary Care (PHASE4)
- Nasal Spray Study in Sjogren's Dry Eye Disease (PHASE4)
- Phase 2 Clinical Trial to Evaluate OC-01 Nasal Spray in Subjects With Neurotrophic Keratopathy (PHASE2)
- Evaluation of the Long Term Follow up of the Efficacy of OC-01 Nasal Spray on Signs and Symptoms of Dry Eye Disease (PHASE2, PHASE3)
- Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK) (PHASE3)
- Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of OC-01 in Adult Chinese With Dry Eye Disease (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Varenicline Tartrate Nasal Spray CI brief — competitive landscape report
- Varenicline Tartrate Nasal Spray updates RSS · CI watch RSS
- Corxel Pharmaceuticals portfolio CI
Frequently asked questions about Varenicline Tartrate Nasal Spray
What is Varenicline Tartrate Nasal Spray?
Varenicline Tartrate Nasal Spray is a Small molecule drug developed by Corxel Pharmaceuticals.
Who makes Varenicline Tartrate Nasal Spray?
Varenicline Tartrate Nasal Spray is developed and marketed by Corxel Pharmaceuticals (see full Corxel Pharmaceuticals pipeline at /company/corxel-pharmaceuticals).
Is Varenicline Tartrate Nasal Spray also known as anything else?
Varenicline Tartrate Nasal Spray is also known as OC-01 (varenicline solution) Nasal Spray.
What development phase is Varenicline Tartrate Nasal Spray in?
Varenicline Tartrate Nasal Spray is FDA-approved (marketed).
Related
- Manufacturer: Corxel Pharmaceuticals — full pipeline
- Also known as: OC-01 (varenicline solution) Nasal Spray
- Compare: Varenicline Tartrate Nasal Spray vs similar drugs
- Pricing: Varenicline Tartrate Nasal Spray cost, discount & access